BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

344 related articles for article (PubMed ID: 19747029)

  • 1. Medicare Part D: selected issues for plan sponsors, pharmacists, and beneficiaries in 2009.
    Stubbings J; DePue RJ
    Am J Manag Care; 2009 Sep; 15(9):645-9. PubMed ID: 19747029
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Medicare Part D policy update and implications for 2010.
    DePue RJ; Stubbings J; Baker DC
    Am J Manag Care; 2010 May; 16(5):e117-20. PubMed ID: 20455637
    [TBL] [Abstract][Full Text] [Related]  

  • 3. PDP or MA-PD? Medicare part D enrollment decisions in CMS Region 25.
    Cline RR; Worley MM; Schondelmeyer SW; Schommer JC; Larson TA; Uden DL; Hadsall RS
    Res Social Adm Pharm; 2010 Jun; 6(2):130-42. PubMed ID: 20511112
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of cost sharing on prescription drugs used by Medicare beneficiaries.
    Goedken AM; Urmie JM; Farris KB; Doucette WR
    Res Social Adm Pharm; 2010 Jun; 6(2):100-9. PubMed ID: 20511109
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Medicare program; Medicare prescription drug benefit. Final rule.
    Centers for Medicare & Medicaid Services (CMS), HHS
    Fed Regist; 2005 Jan; 70(18):4193-585. PubMed ID: 15678603
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Medicare program; Medicare prescription drug discount card. Interim final rule with comment period.
    Centers for Medicare & Medicaid Services (CMS), HHS
    Fed Regist; 2003 Dec; 68(240):69839-927. PubMed ID: 14674398
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Medicare part D: selected issues for plan sponsors, pharmacists, and beneficiaries in 2008.
    Depue R; Stubbings J
    J Manag Care Pharm; 2008; 14(1):50-60. PubMed ID: 18240882
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Medicare Part D: how do vulnerable beneficiaries fare?
    Summer L; Nemore P; Finberg J
    Issue Brief (Commonw Fund); 2008 Apr; 35():1-11. PubMed ID: 18536146
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Medicare Part D: successes and continuing challenges. Impact of Medicare Part D on Massachusetts health programs and beneficiaries.
    Thomas CP; Sussman J; ;
    Issue Brief (Mass Health Policy Forum); 2007 May; (32):1-32. PubMed ID: 17546802
    [TBL] [Abstract][Full Text] [Related]  

  • 10. First-year Medicare Part D prescription drug benefits: medication access and continuity among dual eligible psychiatric patients.
    West JC; Wilk JE; Rae DS; Muszynski IL; Rubio-Stipec M; Alter CL; Sanders KE; Crystal S; Regier DA
    J Clin Psychiatry; 2010 Apr; 71(4):400-10. PubMed ID: 19925748
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Continuing effects of Medicare Part D on rural independent pharmacies who are the sole retail provider in their community.
    Radford A; Mason M; Richardson I; Rutledge S; Poley S; Mueller K; Slifkin R
    Res Social Adm Pharm; 2009 Mar; 5(1):17-30. PubMed ID: 19285286
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of Medicare Part D on independent and chain community pharmacies in rural Illinois--A qualitative study.
    Bono JD; Crawford SY
    Res Social Adm Pharm; 2010 Jun; 6(2):110-20. PubMed ID: 20511110
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Medicare Part D: practical practice information for healthcare providers.
    Moczygemba LR
    J Am Acad Nurse Pract; 2006 Oct; 18(10):457-62. PubMed ID: 16999710
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Falling into the doughnut hole: drug spending among beneficiaries with end-stage renal disease under Medicare Part D plans.
    Patel UD; Davis MM
    J Am Soc Nephrol; 2006 Sep; 17(9):2546-53. PubMed ID: 16855016
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cost minimization of medicare part D prescription drug plan expenditures.
    Patel RA; Lipton HL; Cutler TW; Smith AR; Tsunoda SM; Stebbins MR
    Am J Manag Care; 2009 Aug; 15(8):545-53. PubMed ID: 19670958
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmaceuticals and medical devices: Medicare Part D.
    ; Steiner DJ
    Issue Brief Health Policy Track Serv; 2012 Jan; ():1-37. PubMed ID: 22403844
    [No Abstract]   [Full Text] [Related]  

  • 17. Pharmaceuticals and medical devices: Medicare Part D. End-of-year issue brief.
    Chaps NA
    Issue Brief Health Policy Track Serv; 2009 Jan; ():1-26. PubMed ID: 19301435
    [No Abstract]   [Full Text] [Related]  

  • 18. Assessing the impact of coverage gaps in the Medicare Part D drug benefit.
    Hudson N
    Find Brief; 2008 Apr; 11(3):1-3. PubMed ID: 18441611
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Factors associated with independent pharmacy owners' satisfaction with Medicare Part D contracts.
    Zhang S; Doucette WR; Urmie JM; Xie Y; Brooks JM
    Res Social Adm Pharm; 2010 Jun; 6(2):121-9. PubMed ID: 20511111
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Examining the impact of Part D on nursing home residents.
    Hudson N
    Find Brief; 2010 May; 13(4):1-3. PubMed ID: 21121179
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.